معرفی
Andreas Lundqvist is a Professor at the Department of Oncology-Pathology, Karolinska Institutet. His research focuses on understanding mechanisms of immune escape in solid tumors, particularly investigating NK and T cell regulation. He leads the Cell-based Immune Therapy for Cancer group, aiming to develop novel immunotherapies.
Education & Roles:
- PhD in Immunology, Karolinska Institutet (2003)
- Professor since 2023; Associate Professor (2012–2023); Assistant Professor (2009–2012)
- Prior roles include Staff Scientist and Research Fellow at the National Institutes of Health (NIH) (2003–2008)
Research Interests:
Lundqvist's work targets immune evasion in cancer, with emphasis on NK and T cell dynamics. His group explores tumor microenvironment interactions, immune checkpoint modulation, and biomarker discovery. Recent studies focus on renal cell carcinoma, melanoma, and Hodgkin lymphoma.
Grants & Funding:
- Swedish Childhood Cancer Fund (2024–2025)
- Swedish Research Council (2023–2026)
- Swedish Cancer Society (2022–2024)
Advising & Labs:
Lundqvist supervises a research group including PhD students and postdoctoral fellows. Notable alumni include Dhifaf Sarhan (Karolinska Institutet) and Erik Wennerberg (The Institute of Cancer Research).
